UK researchers have developed what they say is the first model to identify patients who will not respond to methotrexate based on ‘real world data’. The model has flagged anxiety as a significant overlooked predictor of non-response to the conventional DMARD within six months of starting treatment. Writing in Arthritis Research & Therapy, the researchers ...
New prediction tool identifies methotrexate non responders
By Michael Woodhead
24 Jul 2018